Kentucky’s Substance Use Record Confidentiality Rules That Go Beyond HIPAA

Product Pricing
Ready to get started? Book a demo with our team
Talk to an expert

Kentucky’s Substance Use Record Confidentiality Rules That Go Beyond HIPAA

Kevin Henry

HIPAA

August 03, 2026

7 minutes read
Share this article
Kentucky’s Substance Use Record Confidentiality Rules That Go Beyond HIPAA

Kentucky Revised Statutes on Substance Use Confidentiality

Kentucky layers state protections on top of HIPAA and 42 CFR Part 2 to strengthen Substance Use Disorder Record Privacy. The centerpiece is Kentucky Revised Statutes § 222.271, which protects client records maintained by alcohol and drug treatment programs. It largely mirrors 42 CFR Part 2 Compliance, barring disclosure or re-disclosure without valid Patient Consent Regulations or a specific legal basis.

Kentucky Revised Statutes § 222.271 works alongside Kentucky Revised Statutes § 210.235, which makes Cabinet-held behavioral health records confidential. Those records can be shared only for the client’s treatment, with the client’s written consent, under a qualifying court order, or for limited research and auditing under safeguards that remove direct identifiers.

Together, these statutes let you authorize narrowly tailored releases and revoke consent in writing at any time. Unauthorized disclosures can trigger administrative sanctions and civil exposure under state law, in addition to federal penalties when 42 CFR Part 2 applies.

Drug and Alcohol Test Result Protections

Not all drug or alcohol test results are HIPAA records. Employment testing, for example, often falls outside HIPAA. Kentucky Revised Statutes § 351.185 specifically governs testing in mining operations, restricting who may receive results and how they may be used to protect worker privacy and safety.

Under § 351.185, disclosure of a miner’s test results is limited to defined safety and certification purposes, the individual tested, and officials designated by law. Sharing results beyond those channels generally requires the worker’s written consent or a lawful process, reinforcing confidentiality even when HIPAA does not apply.

If your organization conducts testing outside the mining context, treat results as sensitive personal data. Apply patient-style consent forms, limit internal access on a need-to-know basis, and avoid repurposing results for unrelated employment decisions without explicit authorization.

Cabinet for Health and Family Services Record Rules

Kentucky’s Cabinet for Health and Family Services (CHFS) maintains strict confidentiality for behavioral health and substance use records under Kentucky Revised Statutes § 210.235. CHFS facilities and community programs must protect identifying information and disclose it only as permitted by statute and 42 CFR Part 2 Compliance where applicable.

You may obtain your own records or authorize disclosure to a treating provider or case manager. Courts can compel release only through orders that satisfy specificity and necessity standards, and even then, disclosures are narrowly limited to what is essential for the proceeding.

Programs funded or overseen by CHFS should document privacy policies, workforce training, and secure transmission practices. Align those practices with Patient Consent Regulations to ensure consistent protection across paper and electronic systems.

Kentucky Administrative Regulations Compliance

908 KAR 1:320 operationalizes state confidentiality requirements for alcohol and other drug treatment programs. It requires written consent elements that identify the disclosing program, the recipient, the purpose, a clear expiration, and your right to revoke consent at any time.

The regulation also mandates the federal prohibition-on-redisclosure notice on every release, calls for safeguarding paper and electronic records, and expects staff training, incident response, and record-retention practices that match the sensitivity of SUD information.

In practice, standardize consent templates, log all disclosures, and segment Part 2 data in your EHR so only authorized staff can view it. These steps help you satisfy Kentucky rules and 42 CFR Part 2 Compliance simultaneously.

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Federal 42 CFR Part 2 Requirements

42 CFR Part 2 protects records created by federally assisted Substance Use Disorder programs, including opioid treatment programs. A Part 2 record cannot be disclosed unless you give specific written consent or a narrow exception applies under federal law.

Common exceptions include medical emergencies, research or audits, child abuse or neglect reporting, and crimes on program premises or against personnel. Court-ordered disclosures must meet rigorous criteria and are limited to the minimum necessary information to serve the stated purpose.

Part 2 requires a prohibition-on-redisclosure warning and generally bars downstream recipients from sharing the information further unless your consent or another Part 2 exception allows it. HIPAA may apply in parallel, but Part 2 controls whenever it is more protective.

2024 Part 2 Final Rule Updates

On February 16, 2024, HHS finalized major updates to Part 2. The rule took effect on April 16, 2024, with a general compliance date of February 16, 2026, giving programs time to revise policies, forms, and systems.

Key changes allow a single patient consent for treatment, payment, and health care operations across Part 2 programs, HIPAA covered entities, and business associates. Covered recipients may redisclose consistent with HIPAA, except for using SUD records in criminal, civil, or administrative proceedings against you without a proper court order or your consent.

The rule aligns breach notification and enforcement with HIPAA, introduces enhanced notice requirements, and creates a right to request a list of certain disclosures. Kentucky providers should update policies, staff training, notice language, and release-of-information workflows well before the 2026 compliance date.

Patient Rights and Disclosure Controls

You control whether your Substance Use Disorder record is shared. Patient Consent Regulations require clear, specific authorization that names recipients and purposes, sets an expiration, and explains your right to revoke at any time.

You have rights to access and obtain copies of your records, receive a privacy notice, and request amendments. For HIPAA-covered providers, you may also request restrictions on certain disclosures and obtain an accounting or list of specified disclosures where required by federal rules.

Providers must apply need-to-know access, display the prohibition-on-redisclosure notice, and segment Part 2 data so it is not inadvertently mixed with general records. Use minimum-necessary principles for non-treatment disclosures and maintain detailed disclosure logs to demonstrate 42 CFR Part 2 Compliance.

Bottom line: Kentucky’s statutes (including Kentucky Revised Statutes § 222.271, § 351.185, and § 210.235) and 908 KAR 1:320 add state-level guardrails that go beyond HIPAA, while 42 CFR Part 2—and its 2024 updates—set the national floor. When you align consents, policies, and EHR controls to all three, you maximize confidentiality and compliance.

FAQs

How does Kentucky law enhance substance use record confidentiality beyond HIPAA?

Kentucky elevates privacy through Kentucky Revised Statutes § 222.271 and § 210.235, which tightly restrict disclosures of treatment and Cabinet-held records, require tailored consents, and incorporate prohibition-on-redisclosure language. 908 KAR 1:320 operationalizes these protections, and § 351.185 limits employment test result sharing—protections that go beyond HIPAA’s baseline.

What exceptions exist for disclosure under Kentucky statutes?

Exceptions include your written consent, disclosures for treatment and care coordination, bona fide medical emergencies, court orders that meet strict standards, mandatory reporting (such as child abuse or neglect), and research or audits under confidentiality safeguards. For test results, § 351.185 allows limited sharing with designated officials and the tested worker.

How does the 2024 Part 2 Final Rule affect substance use record privacy?

The 2024 rule permits a single consent for treatment, payment, and health care operations and lets HIPAA-covered recipients redisclose as HIPAA allows, while maintaining strict limits on legal use against the patient. It aligns breach notification and enforcement with HIPAA and adds a right to request a list of certain disclosures, with a general compliance date of February 16, 2026.

What patient rights are protected under Kentucky confidentiality rules?

You have the right to confidentiality, to give and revoke consent, to access and copy your records, and to receive clear privacy notices. You can request amendments and, where applicable, limits on certain disclosures. State law also restricts who can see employment-related test results, reinforcing privacy beyond HIPAA and federal Part 2.

Share this article

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Related Articles